Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 1Phase 3 1Phase 1 1

Status

Completed 3Unknown 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Breast 7

Conditions

Breast Neoplasms 13138Neoplasms 10481Carcinoma, Non-Small-Cell Lung 6874Prostatic Neoplasms 6268Colorectal Neoplasms 5948Lung Neoplasms 5105Multiple Myeloma 3577Pancreatic Neoplasms 3563Leukemia, Myeloid, Acute 3510Neoplasm Metastasis 3508Carcinoma, Hepatocellular 3273Ovarian Neoplasms 3168Melanoma 3141Stomach Neoplasms 3057Lymphoma 2983Head and Neck Neoplasms 2604Recurrence 2557Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Colonic Neoplasms 2328Brain Neoplasms 2313Lymphoma, Non-Hodgkin 2269Rectal Neoplasms 2192Uterine Cervical Neoplasms 2191Glioblastoma 2016Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1913Squamous Cell Carcinoma of Head and Neck 1880Lymphoma, Follicular 1848Esophageal Neoplasms 1801

Interventions

pegylated granulocyte colony-stimulating factor 1Trastuzumab 1Omacor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Breastcancer × Clear all
NCT03121248 2023-12-22

HAI-5-III

University Hospital, Ghent

Phase NA Active not recruiting
144 enrolled
Breast

Breastcancer

NCT02996240 2021-03-17

Breast, Omega 3 Free Fatty Acid, Ph 0

The University of Texas Health Science Center at San Antonio

Phase NA Completed
21 enrolled
Breast

Breastcancer

NCT02975128 2020-05-29

BLES

Radboud University Medical Center

Phase NA Terminated
22 enrolled
Breast

Breastcancer

NCT02944604 2019-01-18

The Efficacy and Safety of PEG-rhG-CSF(Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy

Peking University

Phase 4 Completed
240 enrolled
Breast

Breastcancer

NCT03014076 2017-01-09

Immunotherapy Vaccine and Herceptin in Breast Cancer

Cancer Insight, LLC

Phase 1 Completed
30 enrolled
Breast

Breastcancer

NCT02967146 2017-01-05

Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer

Samsung Medical Center

Phase 3 Unknown
170 enrolled
Breast

Breastcancer

NCT02997384 2016-12-20

RIVIERA

Gustave Roussy, Cancer Campus, Grand Paris

Unknown
600 enrolled
Breast

Breastcancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡